Skip to main content
. 2014 Dec 24;13:S109–S608. doi: 10.1111/j.1469-0691.2007.01733.x

Clinical and bacteriological success rates of MXF and COMP therapy in patients with pneumococcal bacteraemia

MXF n/N (%) COMP n/N (%)
Overall clinical success 40/48 (83.3%) 49/64 (76.6%)
Clinical success in patients with severe CAP 13/19 (68.4%) 18/31 (58.1%)
Overall bacteriological success 42/48 (87.5%) 50/64 (78.1%)